All Articles

The utility's strong Q2 results are fueled by massive energy demand from new data centers, prompting a $1B capital plan increase and promising regional growth.

A strategic hire at RegTech firm RiskExec reveals a new reality: AI is no longer just a tool, but a core strategy for navigating financial regulation.

GPGI's Q2 results show a tale of two subsidiaries. While fintech darling CompoSecure hits records, industrial giant Husky faces market drag. Can one system steer both?

With a 32% jump in royalty revenue and a game-changing acquisition, Ligand Pharmaceuticals solidifies its market dominance. But is the growth sustainable?

With a strong cash runway to 2028 and key data expected, Aclaris is advancing a multi-asset portfolio against complex immuno-inflammatory diseases.

Bob's Discount Furniture's impressive Q2 earnings reveal a dual victory: a value proposition resonating with cautious consumers and a massive tariff refund.

Veritas Capital's acquisition of Saber Power isn't just a deal; it's a high-stakes play on the infrastructure backbone of the AI and data center boom.

Lithium Americas secures crucial financing for its Nevada mega-project, a move to navigate peak construction costs and reinforce its role in U.S. EV independence.

Solid growth and a key FDA approval showcase Kenvue's value as it barrels toward a transformative merger, creating a new consumer health powerhouse.

Despite a reported loss, DNOW's record cash flow, aggressive buybacks, and operational wins signal a powerful turnaround. Is this the new blueprint for resilience?

Playtika's Q2 results reveal a strategic pivot. Soaring revenue and DTC growth mask a drop in paying users, signaling a disciplined focus on profit over scale.

Heartland Dental CEO Pat Bauer's Titan Award celebrates his 'doctor-led' vision. But what does this mean for an industry increasingly shaped by private equity?

Opal Therapeutics' organoid platform, backed by a major NSF award, bypasses failed animal models to fast-track cures for endometriosis and fibroids.

F&G's steady dividend pleases income investors, but recent earnings misses and a complex capital structure warrant a closer look at its long-term health.

Cresco Labs posts a 15% revenue jump, touting operational wins ahead of federal reform. But a surprise CFO departure introduces a new variable.

Greenland Energy is scaling back its winter drilling plan. It's not a retreat, but a strategic signal of caution in a high-stakes Arctic balancing act.

Paramount Resources posts a blowout quarter with record-setting Montney wells, raising production guidance while holding spending flat—a feat of capital efficiency.

Enerflex's Q2 results reveal a masterclass in strategy. With a record backlog and fortified balance sheet, the firm is shedding assets to fund its future.

Cross-Border Impact Ventures secures a $58M first close for its second fund, targeting the vastly underserved but rapidly growing women's and children's health market.

Mastech Digital's Q2 results reveal a tale of two segments. While its AI division shows its first growth since 2024, the legacy staffing unit struggles.